Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Condition: Locally Advanced or Metastatic Breast Cancer
NCT06439771
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal | rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.